Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-23

Clinical Trial Update: Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM for ALS (SHED-CAH2023)

View source ↗

Summary

A completed retrospective study assessing the safety and potential therapeutic effects of intravenous SHED-CM in amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHED-CM

Snippet

Sponsor: Hitonowa Medical | Conditions: Amyotrophic Lateral Sclerosis | Status: COMPLETED